Precision medicine is oft spoken about these days, as it is finally addressing the elephant in the room: one size – or, more appropriately, one dose – does not fit all.
Proscia, an AI-enabled pathology solutions software company, has announced the launch of Concentriq Embeddings and the Proscia AI Toolkit, hoping to accelerate precision medicine R&D.
In the era of precision medicine, life sciences teams can utilise real-world data (RWD) to generate actionable real-world evidence (RWE) about how to develop and deliver more targeted medic
Europeans are living longer than ever before – tangible proof of the phenomenal advancements in science and healthcare.1,2 However, it comes with a paradoxical rise in nervous sy
Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of
Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti